Navigation Links
AMPAC Fine Chemicals Names Terry Vollrath Vice President of Operations

RANCHO CORDOVA, Calif., Sept. 23, 2011 /PRNewswire/ -- AMPAC Fine Chemicals LLC (AFC), a wholly-owned subsidiary of American Pacific Corporation (Nasdaq®: APFC), announced that Terence "Terry" Vollrath has joined AFC as Vice President of Operations.  "We are very pleased to have an accomplished leader like Terry to assume responsibility for our extensive multi-plant operations," stated, Aslam Malik, President of AFC.  

Vollrath, a 30-year veteran of the active pharmaceutical ingredient (API) manufacturing industry, has held operational leadership positions with Cody Laboratories, Aerojet Fine Chemicals, and Abbott Laboratories.  

Upon graduation as a Chemical Engineer from the University of Wisconsin, Terry spent 19 years with Abbott Laboratories in areas of increasing responsibility and leadership.  He also earned a Master's Degree in Business Administration from Lake Forest Graduate School of Management in Chicago.

"I am excited by AFC's technology platforms and leadership position in the API marketplace," stated Terry.  "AFC is investing in the future here in California and in Texas, and I look forward to being part of this terrific team."

"Terry brings significant operational knowledge and experience to AFC.  His addition to our management team further solidifies our position as a leading manufacturer of custom small molecule APIs.  With world class cGMP manufacturing capabilities in the United States, we continue to demonstrate our commitment to maintaining the U.S. based assets and services needed by our customers to provide materials of critical importance to health and safety," Aslam added.

ABOUT AMPAC FINE CHEMICALSAFC is a U.S.-based company with demonstrated capabilities in process development, scale-up, and cGMP-compliant commercial production of active pharmaceutical ingredients (APIs) and registered intermediates for pharmaceutical and biotechnology customers. Its specially engineered facilities and experienced staff allow AFC to safely produce highly energetic compounds at commercial scale. In addition, AFC's other technology platforms include production of highly potent compounds, continuous processes and industrial-scale chromatographic separation using simulated moving bed chromatography (SMB).  AFC's operations are located in Rancho Cordova, California and in La Porte, Texas. Additional information about us can be obtained by visiting our web site at

ABOUT AMERICAN PACIFIC CORPORATIONAmerican Pacific Corporation (AMPAC) is a leading custom manufacturer of fine chemicals, specialty chemicals and propulsion products within its focused markets. We supply active pharmaceutical ingredients and advanced intermediates to the pharmaceutical industry. For the aerospace and defense industry we provide specialty chemicals used in solid rocket motors for space launch and military missiles. AMPAC also designs and manufactures liquid propulsion systems, valves and structures for space and missile defense applications. We produce clean agent chemicals for the fire protection industry, as well as electro-chemical equipment for the water treatment industry. Our products are designed to meet customer specifications and often must meet certain governmental and regulatory approvals. Additional information about us can be obtained by visiting our web site at

FORWARD-LOOKING STATEMENTSStatements contained in this press release that are not purely historical are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including without limitation statements regarding AMPAC Fine Chemicals' market position and capabilities. The inclusion of forward-looking statements should not be regarded as a representation by American Pacific Corporation and its affiliates (collectively, "American Pacific") that any of American Pacific's expectations will be achieved.  Actual results may differ materially from future results or outcomes expressed or implied by forward-looking statements set forth in this press release due to risks, uncertainties and other important factors inherent in American Pacific's business.  Factors that might cause actual results to differ include, but are not limited to, those included in the "Risk Factors" section of the Form 10-K for the year ended September 30, 2010 and filed by American Pacific Corporation with the U.S. Securities and Exchange Commission.  Readers of this press release are referred to the filings of American Pacific Corporation with the U.S. Securities and Exchange Commission, including the Form 10-K for Fiscal 2010, our Quarterly Report on Form 10-Q for the quarters ended June 30, 2011, March 31, 2011 and December 31, 2010, and our other filings with the Securities and Exchange Commission, for further discussion of these and other factors that could affect future results. The forward-looking statements contained in this press release are made as of the date hereof and American Pacific assumes no obligation to update for actual results or to update the reasons why actual results could differ materially from those projected in the forward-looking statements, except as required by law.  Technical Contact: William DuBay, Ph.D., Vice President,
Technology and Business Development
AMPAC Fine Chemicals
+1 (800) 311 9668Investor Contact:Deanna Riccardi, Investor Relations Manager
American Pacific Corporation
+1 (702) 735-2200

SOURCE American Pacific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. AMPAC Fine Chemicals Receives Prestigious Award at Californias Annual Statewide Environmental Summit
2. AMPAC Fine Chemicals Partners With Inabata & Co., Ltd. of Japan
3. Ampac Fine Chemicals President Aslam Malik Joins SOCMAs Board of Governors; Industry Veteran Adds Significant Experience to Board
4. AMPAC Fine Chemicals Adds New Capabilities for Clinical Programs
5. New ionator EXP(TM) and ionator HOM(TM) Kill Swine Flu Without Use of Chemicals
6. Sigma-Aldrich Becomes the Sole U.S. and Canada Distributor of Kromasil(R) HPLC Columns Through Agreement With Eka Chemicals
7. Honeywell and Pro-Lab Sign Distribution Agreement for Laboratory Chemicals in Turkey
8. Reportlinker Adds The Global Pharmaceutical Fine Chemicals Market Outlook to 2015
9. European Fine Chemicals Group Ratifies FDAs Proposed Generic Drug User Fees Act (GDUFA)
10. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
11. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
Post Your Comments:
(Date:11/25/2015)... SHENZHEN, China , Nov. 25, ... or the "Company") (NYSE: MR ... marketer of medical devices worldwide, today ... 2015 annual general meeting of shareholders ... 1 11/F, Grand Century, 193 Prince Edward ...
(Date:11/25/2015)... --> --> ... für das Patent über eine neue Hepatitis-B-Behandlung, welches sie ... an Enyo Pharma vergeben haben. Im Rahmen ... und von Edelris gemeinsam mit seinen Partnern Inserm und ... HBV identifiziert, und es wurden neue Inhaltsstoffe entdeckt, die ...
(Date:11/24/2015)... Nov. 24, 2015  Thanks to a donor with ... Mary,s Medical Center,s Sister Diane Grassilli Center for Women,s ... in San Francisco . ... stepped forward with a gift of $617,320 that allowed ... Mammography with Tomosynthesis and Whole Breast Ultrasound. Tomosynthesis, three-dimensional ...
Breaking Medicine Technology:
(Date:11/25/2015)... D.C. (PRWEB) , ... November 25, 2015 , ... Today, ... fatalities on our nation’s roadways has dropped below 10,000 for the first time since ... 10,076 in 2013. , According to data released by the National Highway Traffic Safety ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing ... this disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... announced that it has undertaken significant expansion of its current state of the ... is part of PharmaTech’s strategy to increase its manufacturing capacity as well as ...
(Date:11/25/2015)... ... , ... Many people know of the common symptoms of low thyroid hormone ... But many people who find their cholesterol levels and weight are creeping up are ... if they don’t have any of the other symptoms. , Thyroid hormone plays a ...
(Date:11/25/2015)... ... , ... Since its launch in 2012, the Regenestem brand ... therapies to patients with chronic degenerative medical conditions. Now, the U.S. Patent and ... , Organizations are required to hold a registered trademark in order to make ...
Breaking Medicine News(10 mins):